| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_970bfaebf93b450409d646017acb44b4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate |
2007-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10c03ef89b5aee369036dd92409fcab4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3143f6428e0ad2d80ebe9528457493af |
| publicationDate |
2009-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2316270-A1 |
| titleOfInvention |
NEW CRYSTALLINE FORM OF MOXIFLOXACINO CHLORHYDRATE ANHYDRATE FORM IV. |
| abstract |
New crystalline form of moxifloxacinnanhydrous hydrochloride form IV.n n n The present invention relates to a newnstable polymorphic form of anhydrous moxifloxacin hydrochloride, tona procedure for the preparation of said polymorphic form, andnto pharmaceutical compositions comprising said formnpolymorphic |
| priorityDate |
2007-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |